Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Kyowa Kirin at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Kyowa Kirin brings 2 presentations to ASH 2026 in New Orleans, and exhibits at Booth 1947. Its research centres on antibody-based treatments and transplant preparation. It covers an alternate mogamulizumab dosing plan for cutaneous T-cell lymphoma and a CD117-targeted antibody for stem cell transplant conditioning.

OrganizationASH 2026 Attendance
Kyowa Kirin
Tokyo, Japan
Large pharma
Japanese pharmaceutical company developing antibody-based medicines, including mogamulizumab for cutaneous T-cell lymphoma.
Booth
Exhibiting at Booth 1947
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Kyowa Kirin

Tell us what you sell and we’ll find the people at Kyowa Kirin most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction